Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib

Anita J.W.M. Brouns, Ard van Veelen, G. D.Marijn Veerman, Christi Steendam, Safiye Dursun, Cor van der Leest, Sander Croes, Anne Marie C. Dingemans, Lizza E.L. Hendriks*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
72 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology